Founded in 2007, HeartFlow is a healthcare technology company positioned at the intersection of AI and healthcare to transform how heart disease is diagnosed and treated. The company’s technology provides a non-invasive, personalized cardiac test that assesses coronary artery disease and allows physicians to determine the appropriate treatment plan.
Investment Rationale
Large addressable market for the leading cause of death worldwide
Superior technology that allows for a non-invasive and safer diagnostic
Enter the username or e-mail you used in your profile. A password reset link will be sent to you by email.
Our website uses cookies to give you the best online experience. By using our website, you agree to our use of cookies. For more information, please review our Privacy Policy.
